Clinical trials sponsored by The Second Affiliated Hospital of Chongqing Medical University
4
Recruiting trials
8
Conditions studied
Phase breakdown
Phase 2 2Phase 4 1Not applicable 1
Conditions studied
| Condition | Trials |
|---|---|
| Chronic Hepatitis b | 3 |
| Hepatitis B | 3 |
| Anti-PD-1 Antibody | 2 |
| Lung Cancer (Including Metastatic Cancer) | 1 |
| Lung cancer | 1 |
| Peg-IFNα | 1 |
| Radiation Pneumonitis | 1 |
| Radiation-induced Lung Injury | 1 |
Recruiting trials led by The Second Affiliated Hospital of Chongqing Medical University
- A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (A)
- A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (B)
- ASC22 Combined With Peg-IFNa in Achieving Functional Cure in Patients With Chronic Hepatitis B Virus Infection
- Functional Lung Avoidance Radiotherapy Guided by 4DCT Pulmonary Ventilation Function Imaging: A Prospective Single-arm Clinical Study
Common questions
How many trials is The Second Affiliated Hospital of Chongqing Medical University recruiting for?
The Second Affiliated Hospital of Chongqing Medical University is the lead sponsor of 4 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.